Tus-Pharmaceutical Group Co.,Ltd.’s Net Profit Dropped 44.3% in First Half of 2023

Tus-Pharmaceutical Group Co.,Ltd. (启迪药业集团股份公司) (000590.SZ) reported a net profit of 6.5 million yuan in the first half of 2023, down 44.3% year-on-year.

Meanwhile, the company posted 190.1 million yuan in revenue, up 22.4% year-on-year.

At the end of the reporting period, it had 1.1 billion yuan in total assets and 415.4 million yuan in total liabilities, with a liability-to-asset ratio of 37%.